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WHAT THIS PAPER ADDS
 This paper reports radiation exposure in a large cohort of patients after endovascular repair of the thoracic and abdominal aorta.
Techniques including computer software modelling are used to evaluate the amount of exposure and conﬁrm that the patient can
receive high doses of irradiation, especially after complex repairs. We suggest that efforts to minimise irradiation and closer follow
up of patients that have had high exposures are required.a r t i c l e i n f o
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Objective: Exposure to radiation doses above 2 Gray (Gy) can cause skin burns. There is also a lifetime
cancer risk ofz5.5% for every Sievert (Sv) of radiation. We assessed the radiation burden associated with
endovascular treatment of the aorta.
Method: Thoracic (TEVAR), Infra-renal (IEVAR) and branched/fenestrated (BEVAR/FEVAR) endovascular
aortic repairs were studied. The prospectively recorded dosimetric parameters included: ﬂuoroscopy
time and dose area product (DAP). Exposure ﬁlms, placed underneath 10 patients intra-operatively,
recorded skin dose and were used to calculate skin (Gy) and tissue (Sv) doses.
Results: The TEVAR cohort (n ¼ 232) were younger (p < 0.0001) than BEVAR/FEVAR (n ¼ 53) and IEVAR
(n ¼ 630). The median DAP was higher (p ¼ 0.004) in the BEVAR/FEVAR group compared with IEVAR and
TEVAR: 32,060 cGy cm2 (17,207e213,322) vs 17,300 cGy cm2 (10,940e33,4340) vs 19,440 cGy cm2
(11,284e35,101), respectively. The equivalent skin doses were BEVAR/FEVAR: 1.3 Gy (0.71e8.75); IEVR:
0.71 Gy (0.44e13.7); TEVAR: 0.8 Gy (0.46e1.44). The whole body effective doses were BEVAR/FEVAR:
0.096 Sv (0.052e0.64); IEVR: 0.053 Sv (0.033e1.00); TEVAR: 0.058 Sv (0.034e0.11).
Conclusions: The radiation exposure during endovascular aortic surgery is relatively low for the majority
but some patients are exposed to very high doses. Efforts to minimise intra-operative exposure and graft
surveillance methods that do not use radiation may reduce the cumulative lifetime malignancy risk.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Endovascular procedures play an increasingly important role in
the treatment of vascular disease and have become the treatment of
choice for the aorta. The radiation exposure involved can increase
the morbidity associated with these treatments, by causing tissue
damage and increasing the risk of malignancy.1,2 Transient skinartment of Surgery, 1st Floor,
e Road, London SE17EH, UK.
ai).
ciety for Vascular Surgery. Publisheerythema may be seen within hours of exposure to peak radiation
doses over 2 Gy, with higher exposures risking temporary epilation
and tissue necrosis.3,4 The biological effects of radiation on the
whole body are measured in sieverts (Sv). With every Sv of radia-
tion absorbed by the body there is a 5.5% detriment-weighted
lifetime risk of induced cancer.5 The long term risk associated
with radiation exposure following endovascular aortic procedures,
is often dismissed with the notion that the life expectancy of the
typical patient is relatively short, coupled with the fact that there is
a latent period of around 10 years for malignant transformation
following radiation exposure. Improved standards of care, however,
mean that life expectancy is increasing and signiﬁcant radiation
exposure in the younger patient is of particular concern.6 Moreover,d by Elsevier Ltd. All rights reserved.
Figure 1. (a) A sheet of Gafchromic XR-RV2 ﬁlm after exposure to known radiation
doses. Darker colour signiﬁes higher radiation exposure. (b) calibration curve obtained
from plotting known exposure doses against mean pixel value.
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tomography (CT) can signiﬁcantly add to the burden of radiation
after the initial repair.
Intra-operative radiation exposure during endovascular proce-
dures should be accurately quantiﬁed and attempts made to
minimise this exposure should be a priority. We used validated
techniques to quantify the amount of radiation to which patients
were exposed during repairs of the thoracic and abdominal aorta.
Methods
Prospective data collected on all consecutive Infra-renal aortic
repairs (IEVAR), thoracic endovascular aortic repairs (TEVAR) and
branched/fenestrated endovascular repairs (BEVAR/FEVAR)
between 2003 and 2010 was analysed retrospectively. All repairs
were carried out in an interventional radiology suite. Indirect
measurements recorded by the ﬂuoroscopy equipment were Dose
Area Product (DAP) and the ﬂuoroscopy time. Dose Area Product is
a crude estimate of radiation exposure which reﬂects the radiation
dose and the area of tissue that has been irradiated and does not
reﬂect the peak dose received by one particular area. We therefore
made direct measurements of peak skin radiation exposure for
a cohort of procedures and used software modelling to accurately
quantify the amount of radiation absorbed by the body.
Quantiﬁcation of peak skin exposure dose
A sheet of Gafchromic XR-RV2 ﬁlm (International Specialty
Products, New Jersey, USA) was exposed to a series of known
radiation doses, ranging from 0.06 Gy to 4.0 Gy as seen in Fig. 1a.
The ﬁlm was scanned and analysed using the image analysis soft-
ware Image J (National Institutes of Health, USA) to obtain a cali-
bration curve Fig. 1b.
Prospective datawas then collected using a cohort of 10 patients
(n ¼ 9 IEVAR, n ¼ 1 BEVAR/FEVAR). A sheet of Gafchromic XR-RV2
ﬁlm was placed under the patient during interventions in order to
make a direct measure of the maximum intra-operative skin dose
received (Fig. 2). The ﬁlm was placed in a protective bag, under-
neath the mattress, before the patient was positioned on the
operating table. At the end of each procedure the ﬁlm was scanned
and analysed as described above. The mean pixel value in the
darkest region of the ﬁlm was used to estimate the peak radiation
dose absorbed by the skin using the calibration curve. The largest
possible rectangular region of interest that ﬁtted inside each
uniformly irradiated area of the ﬁlm was used. This area typically
measured greater than 10 cm2.
The ratio of measured skin dose to DAP was found for all 10
patients. The mean value of this ratio was applied to the DAP value
recorded for each of the 915 procedures in order to obtain an
estimate of the peak skin dose for every patient.
Whole body effective dose
The radiation dose absorbed by the body is non-uniform, with
organs absorbing different quantities of radiation and they have
different sensitivities to the radiation absorbed. In order to calcu-
late the effective dose we used the PCXMC software (STUK Radia-
tion and Nuclear Authority, Finland). The software takes into
account variables including: X-ray examination details (parts of the
body exposed, orientation, size of X-ray ﬁeld) and the exposure
itself (kV, DAP and X-ray tube details, including ﬁltration, target
angle and ripple). PCXMC uses Monte Carlo prediction and simu-
lation methods to calculate the amount of energy deposited by the
radiation passing through each organ. These organ doses are thenmultiplied by tissue weighting factors and added together to give
the whole body effective dose.Statistics
Spearman’s rank test was used to assess the correlation between
DAP and ﬂuoroscopy time, and Chi Squared test to compare
proportion of patients exceeding 2 Gy skin dose in each group. All
other variables were compared using a Mann Whitney T-test.
Variables were expressed as median with range or mean with
standard deviation. P values of <0.05 were regarded as statistically
signiﬁcant.Results
The TEVAR cohort (n ¼ 232, age 71, 15e89), which included
patients treated for aortic transection and dissections, were
younger (p < 0.0001) than BEVAR/FEVAR (n ¼ 53, median age 76,
58e85) and IEVAR (n ¼ 630, median age 76, 37e93) Table 1.
The DAP was higher (p ¼ 0.004) in the BEVAR/FEVAR group
compared with IEVAR and TEVAR: 32,060 cGy cm2
[17,207e213,322] vs 17,300 cGy cm2 [10,940e334,340] vs
19,440 cGy cm2 [11,284e35,101], respectively (Fig. 3).
The recorded DAP for the 10 patients for whom Gafchromic ﬁlm
was used was 14,351 cGy cm2 (12,438e20,812). The equivalent skin
dose was 0.6 Gy (0.5e0.85). The mean ratio of the directly
Figure 3. The DAP recordings were signiﬁcantly higher for patients in Branched/
fenestrated (BEVAR/FEVAR) than both infra-renal (IEVAR) and thoracic repairs
(TEVAR).
Figure 2. Gafchromic ﬁlm placed beneath a patient during an endovascular procedure.
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the 10 patients was 4.1  105 (1.82  105).
The volume of contrast used was signiﬁcantly higher in the
BEVAR/FEVAR when compared to the IEVAR and TEVAR, (180 ml
[30e550] vs 105 ml [10e450] vs 140 ml [15e450], p < 0.0001 and
0.0003 respectively). The contrast volume was also signiﬁcantly
higher (p ¼ 0.0001) in thoracic compared with infra-renal repairs.
There was a positive correlation between DAP and ﬂuoroscopy
time in the BEVAR/FEVAR and IEVAR. R ¼ 0.51, (p < 0.0001) and
R ¼ 0.42, (p < 0.0001) respectively, but not TEVAR group (Fig. 4a).
There was a positive correlation between contrast volume and
ﬂuoroscopy (screening) time (Fig. 4b) and also between contrast
volume and DAP (Fig. 4c).
Equivalent skin doses and whole body doses
The skin doses derived using the conversion ratio of 4.1  105
were 0.8 Gy (0.46e1.44) for TEVAR, 0.71 Gy (0.44e13.7) for IEVAR
and 1.3 (0.7e8.7) for BEVAR/FEVAR.Table 1
Patient and procedure characteristics for branched/fenestrated, thoracic and infra-
renal endovascular aortic repairs.
BEVAR/FEVAR
(n ¼ 53)
TEVAR
(n ¼ 232)
IEVAR
(n ¼ 630)
Age 76 (58e85) 71 (15e89) 76 (37e93)
Female 13 (25%) 72 (31%) 67 (11%)
Screening time
(mins)
58 (6.7e212) 10 (1.5e130) 18 (2.4e161)
Peak skin dose
(Gy)
1.3 (0.7e8.7) 0.8 (0.46e1.44) 0.71 (0.44e13.7)
Whole body dose
(Sv)
0.096
(0.0052e0.64)
0.058
(0.034e0.11)
0.053
(0.033e1.00)
Skin dose >2 Gy 17 (31%) 26 (11%) 69 (11%)The software derived whole body radiation doses were 0.058 Sv
(0.034e0.11) for TEVAR, 0.053 Sv (0.033e1.00) for IEVAR and
0.096 Sv (0.052e0.64) for BEVAR/FEVAR.
The numberof patientswho exceeded2Gy (DAP49,000 cGycm2)
were 26 (11%) TEVAR, 69 (11%) IEVAR and 17 (31%) BEVAR/FEVAR
(p < 0.05). Skin erythema or burns were not evident in any of these
patients in the immediate postoperative period.
Discussion
We report radiation exposures for a heterogeneous group of
aortic endovascular procedures showing signiﬁcant exposure to the
skin but a low excess malignancy risk. As expected radiation
exposure was consistently higher for BEVAR/FEVAR repairs with
almost a third of patients exceeding the threshold of 2 Gy in this
group. It is our practice to examine patients exposed to skin doses
above 2 Gy in the immediate postoperative period for skin
erythema and burns, however, we did not ﬁnd any signs of skin
damage at that time point even though some patients were
exposed to doses higher than 2 Gy. A dose of 2G is recognised in the
literature as a threshold that critically increases the risk factor of
developing skin changes but immediate signs remain relatively
uncommon and may be limited to subtle erythema. It should also
be noted that manifestations of skin damage can be delayed and
skin erythema, burns and hair loss can take up to 4 weeks to
develop.5 The patients in the present study were not speciﬁcally
examined for signs of radiation injury in outpatients and signs of
delayed skin damage may have been overlooked. The International
commission on radiological protection recommends that patients
whose maximum cumulative absorbed dose exceeds 1 Gy should
be counselled about the aforementioned effects of radiation
exposure, their general practitioner notiﬁed and should be fol-
lowed up in outpatients.3
Routine dosimetric measures typically recorded include DAP,
ﬂuoroscopy time and contrast volume.2 Dose area product is
a crude measure of exposure that doesn’t take into account the
differences in X-ray beam quality or the size and position of the X-
ray ﬁeld. Although it reﬂects the dose and area of tissue irradiated,
it provides no information regarding the spatial distribution of the
entrance beam on the patient’s skin. The same DAP is therefore
observed with a large ﬁeld and low skin dose, compared with
a small area and large skin dose. The use of Gafchromic ﬁlm and
specialist software phantom models provide a way for calculating
the amount of radiation exposure at the skin level and the amount
absorbed by the body during these procedures respectively. Weiss
Figure 4. (a) There was a positive correlation between the screening time (ST) and the dose area product (DAP) in the BEVAR/FEVAR and IEVAR group but not in TEVAR. There was
a positive correlation between contrast volume and ST (b) as well as between contrast volume and DAP (c) for all categories.
P. Howells et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 393e397396et al.7 reported peak skin doses of 0.75 Gy (0.27e1.25) for 12 infra-
renal endovascular aneurysm repairs using a comparable method
to the present study with Gafchromic ﬁlm. We have reported a skin
dose of 0.71 (0.44e13.7) the larger range may be explained by the
larger sample size in the present study that includes technically
challenging procedures needing prolonged ﬂuoroscopy and
multiple DSA runs and simple tube grafts that only necessitated the
briefest exposures.
The ﬂuoroscopy time correlated positively with the DAP for
BEVAR/FEVAR and IEVAR. For thoracic repairs, ﬂuoroscopy time did
not correlate with DAP and therewas a large exposure despite short
ﬂuoroscopy times in some cases. This may be due to the relatively
high ratio of digital subtraction angiography (DSA) and/or digital
acquisition runs to ﬂuoroscopy during these thoracic repairs. The
ﬂuoroscopy time only includes X-ray exposures in ﬂuoroscopic
mode and would not, therefore, account for the DSA runs. Digital
subtraction angiography allows clear visualisation of blood vessels
in a bony or dense soft tissue environment, but this is at the
expense of a high radiation dose. During some procedures (e.g.
thoracic interventions) the C-arm would have been used more
frequently in a lateral or oblique orientation which produces
a relatively high DAP for short a screening times.
The majority of patients undergoing EVAR are elderly and may
outlive the stochastic effects of radiation exposure before they
manifest. The TEVAR subgroup are, however, younger and the riskin this cohort may be higher. Use of annual surveillance CT scans,
for example in the case of a patient in their 30’s following TEVAR for
aortic trauma, would signiﬁcantly add to the radiation burden.
Walsh et al.8 reported the lifetime risk of CT related cancer in an 80
year old, having yearly CT follow up as 1 in 3000 which rises to 1 in
140 for a 20 year old. A CT scan of the thoracic and abdominal aorta
exposes the patient to an effective dose of 11 mSv which is equiv-
alent to 4.5 years of background radiation and gives an increased
cancer risk of 1 in 1700.9 The radiation burden associated with
follow up imaging in our patient cohort would be the subject of
another study but it seems sensible to use graft surveillance
methods, such as Duplex ultrasound, that do not require radiation.
We have adopted a policy of using duplex imaging for follow up of
infra-renal aortic repairs if the initial follow up CT scan shows
a satisfactory repair.
Awareness of the amount of radiation exposure to both the
surgeon and patient is becoming imperative with the increasing
use of ﬂuoroscopy guided endovascular procedures. The vascular
surgeon has a vital responsibility to monitor and minimise expo-
sure where possible. Strategies to minimise this risk include
intermittent use of ﬂuoroscopy where possible and adjusting the
table position to reduce the air gap between the ﬂuoroscopy
detector and the patient. A smaller air gap reduces radiation scatter
and consequently reduces radiation exposure to both the patient
and the operator.10
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radiation. Identiﬁcation and cannulation of target vessels may need
prolonged ﬂuoroscopy, several DSA runs and the use of large doses
of contrast. Techniques such as “image registration” are being
developed to aid identiﬁcation of aortic branches and their ostia,
thereby reducing ﬂuoroscopy time and contrast usage.11 This
technique relies on computer software to construct a 3 dimensional
representation of the aorta and its branches from a preoperative
contrast CT. This 3D image is overlaid onto intra-operative ﬂuoro-
scopic images allowing continuous visualisation of the position of
target vessel ostia to aid graft positioning and vessel cannulation.
Limitations of the study
Only ten patients, largely IEVAR, were examined using Gaf-
chromic ﬁlm to determine peak skin dose. This inevitably intro-
duces a margin of error for the conversion factor and therefore on
the extrapolated for the entire cohort of mixed endovascular
procedures. The data obtained is very valuable in the setting of
infra-renal aortic repairs but skin exposure values obtained in the
BEVAR/FEVAR and TEVAR cohort using this methodology need to
be interpreted with caution.
Errors in the ﬁlm calibration may have resulted from variation
between individual ﬁlms, the radiation beam quality, accuracy of
the dosimeter used for calibration and the consistency of the tube
output. The patient’s sex, body habitus, individual anatomy, part of
body irradiated, radiation ﬁeld size and radiation source to skin
distance are just some of the other factors that would affect the
dose of radiation absorbed by the body. These were not taken into
account when applying the conversion factors in the present study.
In addition, variations in operator technique such as ﬁeld size,
number and length of DSA runs and tube angulationwill also affect
the skin and whole body effective doses.
Finally, the study would beneﬁt from long term follow up of
patients to determine the long term incidence of malignancy in this
population and whether exposure to higher doses of radiation does
indeed lead to a higher incidence of malignancy.
Conclusions
The risk associatedwith radiation exposure during endovascular
aortic surgery is relatively low for the majority but some patientsare exposed to very high doses. Graft surveillance methods, such as
duplex andMRI, that do not use radiation are important in reducing
the cumulative lifetime malignancy risk.
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